5,6,7,8-四氢-1,6-萘啶-3-醇盐酸盐 | 785774-74-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 中文名称: 5,6,7,8-四氢-1,6-萘啶-3-醇盐酸盐
• 中文别名: 5,6,7,8-四氢-1,6-萘啶-3-醇；5,6,7,8-四氢-1,6-萘啶-3-醇 盐酸盐
• 英文名称: 5,6,7,8-tetrahydro-1,6-naphthyridin-3-ol
• CAS: 785774-74-5
• 化学式: C₈H₁₀N₂O
• mdl: MFCD08273905
• 分子量: 150.18
• InChiKey: ZCZXOFXBMBTCKF-UHFFFAOYSA-N

物化性质

• 沸点：
  424.0±45.0 °C(Predicted)
• 密度：
  1.211

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.375
• 拓扑面积：
  45.2
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  5,6,7,8-四氢-1,6-萘啶-3-醇盐酸盐 在 caesium carbonate 、 三乙胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[pyrrolo[2,1-f][1,2,4]triazin-4-yloxy]-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carboxamide
  参考文献：
  名称：

  [EN] DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
  [FR] DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE ET COMPOSÉS APPARENTÉS ET LEUR UTILISATION DANS LE TRAITEMENT D'ÉTATS MÉDICAUX

  摘要：

  这项发明提供了二氢异喹啉-2(1H)-甲酰胺及相关化合物、药物组合物，以及它们在治疗医疗状况（如癌症）和抑制HPK1活性中的用途。

  公开号：

  WO2019200120A1
• 作为产物：
  描述：

  6-Boc-3-氨基-5,6,7,8-四氢-[1,6]萘啶 在 盐酸 、 sodium nitrite 作用下， 以 水 为溶剂， 反应 3.0h， 以300 mg的产率得到5,6,7,8-四氢-1,6-萘啶-3-醇盐酸盐
  参考文献：
  名称：

  [EN] DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
  [FR] DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE ET COMPOSÉS APPARENTÉS ET LEUR UTILISATION DANS LE TRAITEMENT D'ÉTATS MÉDICAUX

  摘要：

  这项发明提供了二氢异喹啉-2(1H)-甲酰胺及相关化合物、药物组合物，以及它们在治疗医疗状况（如癌症）和抑制HPK1活性中的用途。

  公开号：

  WO2019200120A1

文献信息

• Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
  申请人：Butora Gabor

  公开号：US20080081803A1

  公开（公告）日：2008-04-03

  The present invention is directed to compounds of the formula I: Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

  本发明涉及以下式I的化合物： 其中R1、R2、R3、R4、R5、R6、R7、R8、R9、X、n和虚线如本文所定义，这些化合物可用作趋化因子受体活性的调节剂。特别地，这些化合物可用作趋化因子受体CCR-2的调节剂。
• [EN] METALLO-BETA-LACTAMASE INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] INHIBITEURS DE LA MÉTALLO-BÊTA-LACTAMASE ET LEURS MÉTHODES D'UTILISATION
  申请人：MERCK SHARP & DOHME

  公开号：WO2019135920A1

  公开（公告）日：2019-07-11

  The present invention relates to metallo-β-lactamase inhibitor compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein RA, R1, and Z are as defined herein. The present invention also relates to compositions which comprise a metallo-β-lactamase inhibitor compound of the invention or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, optionally in combination with a beta lactam antibiotic and/or a beta-lactamase inhibitor. The invention further relates to methods for treating a bacterial infection comprising administering to a patient a therapeutically effective amount of a compound of the invention, in combination with a therapeutically effective amount of one or more β-lactam antibiotics and optionally in combination with one or more beta-lactamase inhibitor compounds. The compounds of the invention are useful in the methods described herein for overcoming antibiotic resistance.

  本发明涉及式I的金属β-内酰胺酶抑制剂化合物及其药用盐，其中RA、R1和Z如本文所定义。本发明还涉及包含本发明的金属β-内酰胺酶抑制剂化合物或其药用盐的组合物，以及药用载体，可选择与β-内酰胺类抗生素和/或β-内酰胺酶抑制剂结合使用。本发明还涉及治疗细菌感染的方法，包括向患者施用本发明的化合物的治疗有效量，与一个或多个β-内酰胺类抗生素的治疗有效量组合使用，可选择与一个或多个β-内酰胺酶抑制剂化合物组合使用。本发明的化合物在本文所述方法中用于克服抗生素耐药性。
• An expeditious synthesis of 3-(difluoromethoxy)- and 3-(trifluoromethoxy)-5,6,7,8-tetrahydro-1,6-naphthyridines
  作者：Deodialsingh Guiadeen、Shankaran Kothandaraman、Lihu Yang、Sander G. Mills、Malcolm MacCoss

  DOI：10.1016/j.tetlet.2008.08.083

  日期：2008.10

  An expeditious and concise synthesis of 3-(difluoromethoxy)-5,6,7,8-tetrahydro-1,6-naphthyridine and 3-(trifluoromethoxy)-5,6,7,8-tetrahydro-1,6-naphthyridines is described. Starting from N-benzyl piperidone, the key intermediates leading to these two biologically desirable synthones were rapidly assembled by inverse electron demand Diels-Alder (IEDA) reaction utilizing microwave irradiation. The scope of the microwave methodology developed herein was extended to other ketones. (c) 2008 Elsevier Ltd. All rights reserved.
• TETRAHYDROPYRANYL CYCLOPENTYL TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
  申请人：Merck & Co., Inc.

  公开号：EP1501507B1

  公开（公告）日：2008-05-28
• METALLO-BETA-LACTAMASE INHIBITORS AND METHODS OF USE THEREOF
  申请人：PASTERNAK Alexander

  公开号：US20200375987A1

  公开（公告）日：2020-12-03

  The present invention relates to metallo-β-lactamase inhibitor compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein R A , R 1 , and Z are as defined herein. The present invention also relates to compositions which comprise a metallo-β-lactamase inhibitor compound of the invention or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, optionally in combination with a beta lactam antibiotic and/or a beta-lactamase inhibitor. The invention further relates to methods for treating a bacterial infection comprising administering to a patient a therapeutically effective amount of a compound of the invention, in combination with a therapeutically effective amount of one or more β-lactam antibiotics and optionally in combination with one or more beta-lactamase inhibitor compounds. The compounds of the invention are useful in the methods described herein for overcoming antibiotic resistance.